DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Jin F, Robeson M, Zhou H et al.
The pharmacokinetics and safety of idelalisib in subjects with moderate or severe hepatic impairment.
J Clin Pharmacol 2015; Mar 27.
DOI: 10.1002/jcph.504.
We do not assume any responsibility for the contents of the web pages of other providers.